AC Immune

AC Immune is a clinical-stage biopharmaceutical company focused on developing precision medicine for neurodegenerative diseases. Founded in 2003 and headquartered in Lausanne, Switzerland, AC Immune has established itself as a global leader in the field. They leverage two proprietary technology platforms, SupraAntigen® and Morphomer®, to develop a diverse pipeline of therapeutic and diagnostic candidates targeting Alzheimer's disease, Parkinson's disease, and other NeuroOrphan diseases. AC Immune's commitment to innovation and research has led to numerous partnerships with industry giants, including Takeda, Janssen Pharmaceuticals, and Eli Lilly and Company, securing significant funding and validating their scientific excellence.

AC Immune's comprehensive approach integrates therapeutic and diagnostic development, aiming to diagnose, treat, and ultimately prevent neurodegenerative diseases. They are actively advancing a robust pipeline of clinical-stage programs, including active immunotherapies, antibodies, small molecule drugs, and diagnostic agents. AC Immune's focus on precision medicine and its commitment to addressing the global burden of neurodegenerative diseases position them as a key player in shaping the future of this rapidly growing field.

AC Immune offers competitive benefits and a stimulating work environment to its employees. The company's culture and values emphasize team spirit, open communication, and a passion for winning, which contributes to a positive and supportive atmosphere.

AC Immune is a clinical-stage biopharmaceutical company dedicated to pioneering precision medicine for neurodegenerative diseases. They are developing a broad pipeline of first- and best-in-class therapeutics and diagnostics to diagnose, treat, and prevent diseases like Alzheimer's, Parkinson's, and certain rare indications. Their mission is to address the growing global burden of neurodegeneration through innovative science and cutting-edge technology platforms, ultimately aiming to improve the lives of patients and their families.

AC Immune fosters a collaborative and innovative culture that values teamwork, open communication, and a passion for finding a cure for neurodegenerative diseases. They emphasize entrepreneurship, modesty, and a drive to succeed while promoting a diverse and inclusive environment where all employees feel valued and respected.

AC Immune embraces diversity and inclusion as a core value. The company is committed to equal opportunity for all employees, regardless of nationality, race, religion, political opinion, sex, age, sexual orientation, cultural background or lifestyle. The company is proud to be an international and multicultural organization, recognizing that the success of AC Immune relies on the valuable contributions of each individual bringing their own unique perspective and experiences.